SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Parabilis Medicines Reports Q3 2026 Results, Holds $1.1 Billion in Cash

Parabilis Medicines reported third-quarter 2026 revenue of $2.1 million and a net loss of $44.5 million, compared with no revenue and a $33.5 million net loss a year earlier. Cash, cash equivalents and marketable securities totaled $1.1 billion at quarter-end, which the company expects to fund oper…

PBLS

Related stories